Filtered By:
Source: Stroke
Drug: Coumadin

This page shows you your search results in order of relevance. This is page number 6.

Order by Relevance | Date

Total 77 results found since Jan 2013.

Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study Clinical Sciences
Conclusions— Resuming warfarin therapy within 90 days after ICH in patients with atrial fibrillation is associated with a decrease in average hospitalization costs.
Source: Stroke - March 27, 2016 Category: Neurology Authors: Vestergaard, A. S., Skjoth, F., Lip, G. Y. H., Larsen, T. B. Tags: Atrial Fibrillation, Mortality/Survival, Quality and Outcomes, Intracranial Hemorrhage Clinical Sciences Source Type: research

Cerebral Microbleeds in Murine Amyloid Angiopathy Basic Sciences
Conclusions—Anticoagulation with warfarin or dabigatran for 3 to 4 months does not promote the formation of CMBs in aged APP23 mice. Nevertheless, warfarin but not dabigatran is associated with a higher risk of extensive intracerebral hemorrhage, suggesting that this model may allow preclinical safety evaluation of antithrombotic therapies.
Source: Stroke - July 24, 2017 Category: Neurology Authors: Marilena Marinescu, Li Sun, Marc Fatar, Andreas Neubauer, Lothar Schad, Joanne van Ryn, Lorenz Lehmann, Roland Veltkamp Tags: Animal Models of Human Disease, Basic Science Research, Translational Studies Original Contributions Source Type: research